Is this article legit?

In a recent transaction, Laura E. Niklason, President, CEO, and Director of Humacyte, Inc. (NASDAQ:HUMA), has bolstered her stake in the company by purchasing shares valued at approximately $8,000. The acquisition, which took place on August 29, 2024, involved 1,222 shares of common stock at a price of $6.545 each.

This purchase reflects a continued commitment from Niklason to the company she leads. Following the transaction, her direct ownership in Humacyte, Inc. has increased to 242,054 shares.